Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

The transcriptomic effect of induced LRIG1 expression in NPC cells


ABSTRACT: As LRIG1 known to be a negative regulator of EGFR, we postulate that restored LRIG1 expression will change the transcription profile through the regulation of EGFR as well as its downstream signal cascades. Thus, we conducted a time-course microarray study to examine the effect of restored LRIG1 expression in NPC line, TW01-LG1/a, which the LRIG1 expression is under the control of a promoter with Doxycycline response element. We established stable transfectants of the LRIG1 gene in the TW01 cells which the expression of LRIG1 protein was barely detectable. To control the expression of LRIG1, the coding sequences were placed under the control of a promoter with doxycycline (Dox)-response element using the Tetoff system. Thus the LRIG1 expression could be turn on by removing Dox from the culture medium. Cellular total RNA were harvested along a time course of 12, 24, 36, and 48 hr following LRIG1 turn on expression, and then subjected to exon array analysis (Affymatrix Human Gene 1.0 ST), using the LRIG1 non-expressing sample (with Dox) as control for all comparison. For each time-point, a biological replicate was included.

ORGANISM(S): Homo sapiens

SUBMITTER: Chia Lee 

PROVIDER: E-GEOD-37349 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

LRIG1 modulates aggressiveness of head and neck cancers by regulating EGFR-MAPK-SPHK1 signaling and extracellular matrix remodeling.

Sheu J J-C JJ   Lee C-C CC   Hua C-H CH   Li C-I CI   Lai M-T MT   Lee S-C SC   Cheng J J   Chen C-M CM   Chan C C   Chao S C-C SC   Chen J-Y JY   Chang J-Y JY   Lee C-H CH  

Oncogene 20130429 11


EGFR overexpression and chromosome 3p deletion are two frequent events in head and neck cancers. We previously mapped the smallest region of recurrent copy-number loss at 3p12.2-p14.1. LRIG1, a negative regulator of EGFR, was found at 3p14, and its copy-number loss correlated with poor clinical outcome. Inducible expression of LRIG1 in head and neck cancer TW01 cells, a line with low LRIG1 levels, suppressed cell proliferation in vitro and tumor growth in vivo. Gene expression profiling, quantit  ...[more]

Similar Datasets

2013-05-02 | GSE37349 | GEO
2009-01-01 | E-TABM-574 | biostudies-arrayexpress
2024-08-16 | GSE241153 | GEO
2019-01-01 | GSE108658 | GEO
2024-07-08 | GSE263575 | GEO
2014-12-31 | GSE37994 | GEO
2021-03-18 | GSE168189 | GEO
2023-07-26 | GSE229912 | GEO
2010-12-20 | GSE25080 | GEO
2015-12-09 | E-GEOD-66479 | biostudies-arrayexpress